COVID19 therapeutics: Expanding the antiviral arsenal

EBioMedicine. 2021 Apr:66:103289. doi: 10.1016/j.ebiom.2021.103289. Epub 2021 Mar 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • SARS-CoV-2

Substances

  • Antiviral Agents